New COVID-19 antibody drug OK’d to protect most vulnerable
People who could benefit from the antibody drug include cancer patients, organ transplant recipients and people taking immune-suppressing drugs for conditions like rheumatoid arthritis.
People who could benefit from the antibody drug include cancer patients, organ transplant recipients and people taking immune-suppressing drugs for conditions like rheumatoid arthritis.
In their most public, forceful protest to date, Republicans led by Sen. Mike Braun of Indiana muscled to passage a proposal that aims to repeal rules ordering large private businesses to require vaccination or implement comprehensive coronavirus testing for their workers.
The state on Wednesday reported 80 more deaths from COVID-19, a two-day total of 173. The seven-day average of deaths from COVID rose from 23 to 27 per day.
Deaths are running close to 1,600 a day on average, back up to where they were in October. And the overall U.S. death toll less than two years into the crisis could hit another heartbreaking milestone, 800,000, in a matter of days.
The order came in response to a lawsuit from several contractors and seven states. It applies across the U.S. because one of those challenging the order is the trade group Associated Builders and Contractors Inc.
Pfizer and its partner BioNTech said that while two doses may not be protective enough to prevent infection, lab tests showed a booster increased by 25-fold people’s levels of virus-fighting antibodies against the omicron variant.
The Indiana State Department of Health on Tuesday reported 93 more deaths from COVID-19, increasing the state’s pandemic death toll to 17,230.
Indiana Gov. Eric Holcomb said the pandemic remains a real threat and is taking lives, but he maintains that the state’s role is to provide vaccines and other resources, not impose vaccine requirements or mask mandates.
Initial data indicate that omicron may be more transmissible even than delta, the variant that became dominant throughout the world this summer.
The Quebec City company said it will seek Canadian approval “imminently” and has also begun the process to file with regulators in the United States, United Kingdom and other countries.
Major corporations that had planned to shepherd all their employees back into offices in early 2022 now have to decide whether those dates make sense in light of further evidence of the pandemic’s unpredictability.
Across the state, 2,408 people were hospitalized for COVID-19 Saturday. That’s up from a recent low of 1,209 on Nov. 6, and six times the number of people hospitalized from COVID-19 at the year-to-date low mark of 369 on June 24.
The omicron variant is likely to have picked up genetic material from another virus that causes the common cold in humans, according to a new preliminary study.
U.S. health officials said while the omicron variant of is rapidly spreading throughout the country, early indications suggest it might be less dangerous than delta, which continues to drive a surge of hospitalizations.
CEO Ugur Sahin told Reuters on Friday that he could foresee a scenario where coronavirus vaccine shots became annual, like flu shots.
The omicron variant of COVID-19, which had been undetected in the United States before the middle of this week, had been discovered in at least five states by late Thursday.
COVID-19 patients now occupy 26.3% of Indiana’s intensive care unit beds.
A person in California who had been vaccinated against COVID-19 became the first in the United States to have an identified case of the omicron variant, the White House announced Wednesday.
The return of stricter COVID-19 restrictions to fight the latest variant has already left some travelers stranded. For many tourism businesses, it’s also threatening hopes of an upcoming holiday boost this year.
The Centers for Disease Control and Prevention said in a Tuesday statement that it was working toward requiring that all air travelers to the U.S. be tested for COVID-19 within a day before boarding their flight.